Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 57 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

39%

22 trials in Phase 3/4

Results Transparency

5%

2 of 38 completed trials have results

Key Signals

4 recruiting2 with results

Enrollment Performance

Analytics

Phase 1
20(40.0%)
Phase 3
13(26.0%)
Phase 4
9(18.0%)
Phase 2
6(12.0%)
N/A
2(4.0%)
50Total
Phase 1(20)
Phase 3(13)
Phase 4(9)
Phase 2(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (57)

Showing 20 of 57 trials
NCT07568652Phase 1Completed

Clinical Trial to Evaluate the Pharmacokinetics and Safety Between the Single Administration of HL1113 and the Concomitant Administration of HL1113R1 and HL1113R2 for Healthy Subjects in Fasting State

Role: lead

NCT07552389Phase 3Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus

Role: lead

NCT07380867Not ApplicableEnrolling By Invitation

Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.

Role: collaborator

NCT06078592Phase 4Completed

Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive

Role: collaborator

NCT06642987Phase 1Completed

Study to Evaluate the Bioequivalence of Vonopzan Tablet 20mg(Vonoprazan Fumarate) and Vocinti Tablet 20mg in Healthy Adult Subjects.

Role: lead

NCT06475872Phase 1Completed

Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects

Role: lead

NCT06434792Phase 2Recruiting

Study to Evaluate Efficacy and Safety of Bronpass Tab. in Patients With Chronic Obstructive Pulmonary Disease

Role: lead

NCT06188234Recruiting

The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab

Role: lead

NCT06191614Completed

DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy

Role: lead

NCT06246331Recruiting

Evaluation of the Clinical Efficacy and Safety of BriTurn Injection or BrisTurn Prefilled Injection

Role: lead

NCT06214832Unknown

An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)

Role: lead

NCT06204380Unknown

An Observational Study on the Identification of Prescription Patterns of STAFEN Cap

Role: lead

NCT06172530Unknown

Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye Drops

Role: lead

NCT06130124Unknown

S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement

Role: lead

NCT06078605Not ApplicableUnknown

Efficacy of Nicotinamide on Retinal Ganglion Cell Functions in Glaucoma Patients

Role: collaborator

NCT06038084Phase 4Completed

Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule

Role: collaborator

NCT05358080Phase 4Unknown

Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy

Role: lead

NCT04882228Phase 4Unknown

Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)

Role: lead

NCT04606329Phase 3Completed

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)

Role: lead

NCT04667624Phase 1Completed

Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult Volunteers

Role: lead